PFIZER ENDS ALZHEIMER

W. Kofler

Abstract

Pfizer, the worlds greatest pharmaceutical company (business volume 2016 52,8 billion US$) has ended its efforts in Alzheimer — research. The decision was conclusive: There is no realistic assumption that the invested money can be recov

Language: english

Download

Summary

W. Kofler
PFIZER ENDS ALZHEIMER // Electronic periodical “Herald of the International Academy of Sciences. Russian Section”, 2018. Issue #1: 56—62